Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

H1N1 influenca virus particle
© NIAID

Dampened immunity during pregnancy promotes evolution of more virulent flu

During pregnancy, a mother’s immune system is suppressed to protect the fetus, which is perceived as a foreign body because it is genetically different. A partly DZIF funded study in mice found that

Memento Award winners (from the left: Peter Kremsner and Carsten Köhler from the Tübingen Institute of Tropical Diseases
© Universitätsklinikum Tübingen

Memento Award 2017 goes to tropical disease specialists from Tübingen

This year, the Memento Research Award for neglected diseases goes to Dr Carsten Köhler and Prof Peter Kremsner from the Institute of Tropical Diseases at the University Hospital Tübingen. With this

Pseudomonas aeruginosa
© CDC_Janice Haney Carr

A list of pathogens sets priorities for antibiotic research

The spread of antibiotic resistant bacteria is causing concern—and the call for new agents is getting louder and louder. But which antibiotics are needed most urgently? Today, for the first time, the

HIV infection: The strategy of resting cells

The human immunodeficiency virus has to overcome major obstacles to infect inactive immune cells. DZIF scientists have investigated the defence mechanism of these cells and found indications of a new

Aedes aegypti mosquito: a vector for the transmission of Zika virus
© cdc/James Gathany

Stem cell research permits insight into early brain development disorders in Zika virus infections

Since autumn 2015, the Zika virus epidemic has been causing marked increases in the birth of babies with much too small heads, or so-called “microcephaly”, especially in South and Central America. The

Andreas Peschel
© DZIF/ScienceRelations

Targeting antibiotic-resistant bacteria specifically and promptly

The spread of antibiotic-resistant bacteria is cause for concern–and no longer constitutes a problem that only hospitals face. In the current issue of Science, DZIF scientists from the University of

The World Health Organization reports that some 214 million people became infected with malaria in the year 2015 alone
© Universität Tübingen

New malaria vaccine effective in clinical trial

Researchers of the University of Tübingen and DZIF in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ

An infection with Epstein-Barr virus, EBV, here stained in green, can cause cancer
© CDC/Dr. Paul M Feorino

Epstein-Barr virus and cancer: New tricks from an old dog

Almost everybody has it: Scientists estimate that approximately 98 percent of adults around the world are infected with the Epstein-Barr virus. In rare cases, an infection with this virus causes

Oumou Maiga-Ascofaré
© DZIF

"Good to see both sides"

Oumou Maiga-Ascofaré is currently working as a research fellow at the Bernhard Nocht Institute for Tropical Medicine in Hamburg and at the Kumasi Centre for Collaborative Research in Tropical Medicine

SC83288 was effective in the late stages of malaria
© NIAID

Successful preclinical tests for new agent against severe malaria

Severe malaria, caused by the Plasmodium falciparum parasite, causes dangerous circulatory disorders and neurological complications. If the affected person is not treated immediately, the disease will